A new study reveals how provider bias and stigma in reproductive health settings limit care for young, unmarried, and childless women—and how targeted interventions can help reduce these barriers.

A panelist highlights that at ASCO 2025, a landmark phase 3 trial showed a new treatment significantly reduced moderate-to-severe hot flashes in patients with breast cancer receiving endocrine therapy, with rapid and sustained symptom relief and high patient continuation rates over 2 years.

A panelist explains that although hormone replacement therapy is contraindicated in patients with breast cancer due to recurrence risks, new nonhormonal treatments targeting neurokinin receptors in the brain offer promising relief for vasomotor symptoms without interfering with endocrine therapy.

Health care providers are using short-form videos on TikTok to educate young women about Pap tests, breaking down barriers with engaging, accessible content.

New research shows up to 17% of reproductive-aged women visit crisis pregnancy centers, raising alarms over misinformation and lack of regulation.

In a recent study, prenatal PFAS exposure was linked to higher adolescent blood pressure, with stronger effects in boys and children born to non-Hispanic Black mothers.

In response to recent threats and attacks, the American College of Obstetricians and Gynecologists urges stronger protections for clinicians and reaffirms support for safe, accessible reproductive care.

A new study finds that mailing human papillomavirus self-collection kits, especially with patient navigation support, significantly boosts cervical cancer screening rates.

A new study reveals that children born to mothers with high blood pressure during pregnancy face a significantly increased risk of seizures, potentially because of brain inflammation.

The American Academy of Pediatrics urges clinicians to offer confidential, adolescent-centered contraceptive care using evidence-based, equity-informed approaches.

A large study finds that women working night or irregular shifts face significantly higher odds of moderate to severe asthma, unlike their male counterparts.

New research reveals that women with endometriosis face increased risks of rheumatoid arthritis, osteoarthritis, and multiple sclerosis because of shared genetic and immune pathways.

A study of adolescents with pathology-confirmed endometriosis reveals common symptoms such as progressive dysmenorrhea and heavy bleeding.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study found that women with colorectal cancer face an increased long-term risk of pain during sex, early menopause, and pelvic disease.

A new study suggests a strong association between hyperinsulinemia and abnormal uterine bleeding, pointing to shared risk factors that could inform future prevention and treatment strategies.

A panelist notes that although chemotherapy’s adverse effects are intense but short-lived, endocrine therapy for hormone receptor–positive breast cancer involves persistent symptoms over several years, making symptom management essential for patient adherence and quality of life.

A panelist discusses how endocrine therapy remains the cornerstone of treatment for hormone receptor–positive, HER2-negative breast cancer, emphasizing its role in reducing relapse risk and mortality while highlighting the importance of tolerability and individualized care across the subtype’s heterogeneous presentations.

A retrospective study finds comparable pregnancy rates between PPOS and GnRH antagonist protocols, with a trend toward improved blastocyst outcomes in PPOS cycles.

A new study shows extrauterine cerebellar ultrasound is a reliable, low-cost method to assess gestational age after fetal or neonatal death, especially in low-resource settings.

Vaccinating pregnant women at least 5 weeks before delivery significantly improves transplacental transfer of respiratory syncytial virus antibodies, offering better early protection for infants.

Childhood adversity may raise endometriosis risk, with exposure to violence linked to a twofold increase, a Swedish study finds.

A recent study presented at ACOG 2025 highlights the potential of once-weekly secnidazole oral granules as an effective long-term therapy for recurrent bacterial vaginosis.

New research reveals that women with eclampsia show significantly higher rates of brain abnormalities, offering insight into unexplained neurologic symptoms during pregnancy.

Daily trimethoprim–sulfamethoxazole in pregnancy reduced preterm births, especially in women with HIV, but did not significantly affect birth weight.